A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

Summary

The purpose of this study is to evaluate the efficacy of abatacept compared to placebo in patients with Sjögren's Syndrome.

Timeline

Start

2016-12-06

Primary completion

2018-08-07

Completion

2019-07-23

Outcome

Missed primary endpoint

registry analysis (superiority test); Abatacept - Double Blind Treatment Period vs Placebo - Double Blind Treatment Period; p = 0.4421; longitudinal repeated measures analysis NCT02915159 ↗

Drugs

Indications